Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women

Journal of Hypertension

Volumn 35, Issue 1, 2017, Pages 89-97

  Cunha, Ana Rosa ^a   D'El Rei, Jenifer ^a   Medeiros, Fernanda ^b   Umbelino, Bianca ^a   Oigman, Wille ^a   Touyz, Rhian M ^c   Neves, Mario F ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Arterial stiffness; Endothelial dysfunction; Flowmediated dilation; Hypertension; Magnesium; Pulse wave velocity

Indexed keywords

GLUCOSE; HYDROCHLOROTHIAZIDE; LIPID; MAGNESIUM; MAGNESIUM CHELATE; MAGNESIUM DERIVATIVE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD BIOCHEMISTRY; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FLOW MEDIATED DILATATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MIDDLE AGED; MONOTHERAPY; NUTRITIONAL PARAMETERS; PERIPHERAL ARTERIAL TONOMETRY; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASODILATATION; AGED; DRUG EFFECTS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGED; BLOOD PRESSURE; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; HYPERTENSION; MAGNESIUM; MIDDLE AGED; PULSE WAVE ANALYSIS;

EID: 84992146681     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001129     Document Type: Article

References (58)

1. Touyz RM, Milne FJ, Reinach SG. Intracellular Mg2+, Ca2+, Na2+ and K+ in platelets and erythrocytes of essential hypertension patients: relation to blood pressure. Clin Exp Hypertens A 1992; 14:1189-1209.
2. Resnick LM, Gupta RK, DiFabio B, Barbagallo M, Mann S, Marion R, Laragh JH. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade. J Clin Invest 1994; 94:1269-1276.
3. Pikilidou MI, Befani CD, Sarafidis PA, Nilsson PM, Koliakos GG, Tziolas IM, et al. Oral calcium supplementation ambulatory blood pressure and relation to changes in intracellular ions and sodium-hydrogen exchange. Am J Hypertens 2009; 22:1263-1269.
4. Touyz RM, Milne FJ. Magnesium supplementation attenuates, but does not prevent, development of hypertension in spontaneously hyper-tensive rats. Am J Hypertens 1999; 12:757-765.
5. Touyz RM, He Y, Montezano AC, Yao G, Chubanov V, Gudermann T, Callera GE. Differential regulation of transient receptor potential mel-astatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290:R73-R78.
6. Brown IJ, Elliott P, Robertson CE, Chan Q, Daviglus ML, Dyer AR, et al. Dietary starch intake of individuals and their blood pressure: the International study of macronutrients and micronutrients and blood pressure. J Hypertens 2009; 27:231-236.
7. Hadjistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Hitoglou-Makedou A, et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010; 16:CR307-CR312.
8. Kisters K, Nguyen MQ, von Ehrlich B, Liebscher DH, Hausberg M. Low magnesium status and diabetes mellitus and hypertension. Clin Neph-rol 2009; 72:81-82.
9. Yamori Y, Mizushima S. A review of the link between dietary magnesium and cardiovascular risk. J Cardiovasc Risk 2000; 7:31-35.
10. Al-Delaimy WK, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 2004; 23:63-70.
11. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol 2008; 19:50-56.
12. Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010; 23:131-137.
13. Tammaro P, Smith AL, Crowley BL, Smirnov SV. Modulation of the voltage-dependent K+ current by intracellular Mg2+ in rat aortic smooth muscle cells. Cardiovasc Res 2005; 65:387-396.
14. Rodriguez-Moran M, Simental Mendia LE, Zambrano Galvan G, Guerrero-Romero F. The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 2011; 24:156-162.
15. Touyz RM. Magnesium in clinical medicine. Front Biosci 2004; 9:1278-1293.
16. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopatho-logical implications. Arch Biochem Biophys 2007; 458:48-56.
17. Chacko SA, Sul J, Song Y, Li X, LeBlanc J, You Y, et al. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am J Clin Nutr 2011; 93:463-473.
18. Spasov AA, Zheltova AA, Kharitonov MV. Magnesium and the oxidative stress. Ross Fiziol Zh Im I M Sechenova 2012; 98:915-923.
19. Salmonowicz B, Krzystek-Korpacka M, Noczynska A. Trace elements, magnesium, and the efficacy of antioxidant systems in children with type 1 diabetes mellitus and in their siblings. Adv Clin Exp Med 2014; 23:259-268.
20. Kisters K, Gremmler B, Hausberg M. Magnesium and arterial stiffness. Hypertension 2006; 47:e3.
21. Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys 2007; 458:33-39.
22. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 2008; 294:H1103-H1118.
23. Ferre S, Baldoli E, Leidi M, Maier JA. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endo-thelial cells via activation of NFkB. Biochim Biophys Acta 2010; 1802:952-958.
24. Yasmin. McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkin-son IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24:969-974.
25. Landmesser U, Drexler H. Endothelial function and hypertension. Curr Opin Cardiol 2007; 22:316-320.
26. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thick-ness: the ARIC study. Atherosclerosis risk in communities study. J Clin Epidemiol 1995; 48:927-940.
27. Maier JA. Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med 2003; 24:137-146.
28. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico city diabetes study. Diabetes Care 1996; 19:1138-1141.
29. O'Brien E, Atkins N. A comparison of the British Hypertension Society and Association for the Advancement of Medical Instrumentation protocols for validating blood pressure measuring devices: can the two be reconciled? J Hypertens 1994; 12:1089-1094.
30. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014; 45:388-393.
31. Solati M, Ouspid E, Hosseini S, Soltani N, Keshavarz M, Dehghani M. Oral magnesium supplementation in type II diabetic patients. Med J Islam Repub Iran 2014; 28:67.
32. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012; 66:411-418.
33. Jee SH, Miller ER 3rd, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15:691-696.
34. Hatzistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Zebekakis PE, et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hyper-tens 2009; 22:1070-1075.
35. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res 2003; 16:183-191.
36. Galli-Tsinopoulou A, Maggana I, Kyrgios I, Mouzaki K, Grammatiko-poulou MG, Stylianou C, Karavanaki K. Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus. J Diabetes 2014; 6:369-377.
37. Goff DC Jr, D'Agostino RB Jr, Haffner SM, Saad MF, Wagenknecht LE. Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the insulin resistance atherosclerosis study. Diabetes Care 2000; 23:1006-1011.
38. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997; 10:346-355.
39. Kishimoto Y, Tani M, Uto-Kondo H, Saita E, Iizuka M, Sone H, et al. Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br J Nutr 2010; 103:469-472.
40. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 1997; 78:737-750.
41. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2008; 196:413-419.
42. Lal J, Vasudev K, Kela AK, Jain SK. Effect of oral magnesium supple-mentation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India 2003; 51:37-42.
43. Nasri H, Baradaran HR. Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy 2008; 109:302-306.
44. Gunther T. Na+/Mg2+ antiport in non-erythrocyte vertebrate cells. Magnes Res 2007; 20:89-99.
45. Levitsky DO, Takahashi M. Interplay of Ca(2+) and Mg (2+) in sodium-calcium exchanger and in other Ca(2+)-binding proteins: magnesium, watchdog that blocks each turn if able. Adv Exp Med Biol 2013; 961:65-78.
46. Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJ, et al. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 2013; 97:1299-1306.
47. Cunha AR, Medeiros F, Umbelino B, Oigman W, Touyz RM, Neves MF. Altered vascular structure and wave reflection in hypertensive women with low magnesium levels. J Am Soc Hypertens 2013; 7:344-352.
48. Afsar B, Elsurer R. The relationship between magnesium and ambulatory blood pressure, augmentation index, pulse wave velocity, total peripheral resistance, and cardiac output in essential hypertensive patients. J Am Soc Hypertens 2014; 8:28-35.
49. Maier JA, Malpuech-Brugere C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004; 1689:13-21.
50. Yang ZW, Gebrewold A, Nowakowski M, Altura BT, Altura BM. Mg(2+)-induced endothelium-dependent relaxation of blood vessels and blood pressure lowering: role of NO. Am J Physiol Regul Integr Comp Physiol 2000; 278:R628-R639.
51. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984; 108:188-193.
52. Touyz RM. Magnesium and hypertension. Curr Opin Nephrol Hyper-tens 2006; 15:141-144.
53. Houston M. The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 2011; 13:843-847.
54. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000; 102:2353-2358.
55. Shechter M. Magnesium and cardiovascular system. Magnes Res 2010; 23:60-72.
56. Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Vascular biology of magnesium and its transporters in hypertension. Magnes Res 2010; 23:S207-S215.
57. Mortazavi M, Moeinzadeh F, Saadatnia M, Shahidi S, McGee JC, Minagar A. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol 2013; 69:309-316.
58. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40:1075-1082.